VIVO Report

Meridian Bioscience, Inc.
Stock Exchange: NASDAQ
Sector: healthcare
25.16
Last session price
25.16
Price now
Currency: USD
Reporting currency: USD
ISIN: US5895841014
INN:
.

VIVO financial statements

* Numbers in millions
Year
 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 TTM
Capitalization *
 638 832 647 696 631 591 680 415 735 814 1 088
EV *
 606 787 604 646 642 589 671 428 752 830 830
Stock price $
 15.5327 20.1699 15.6134 16.7105 15.0281 14.0118 16.0715 9.74 17.15 18.81 25.16
Number of shares *
 41 41 41 42 42 42 42 43 43 43 43
EPS
 0,81 0,92 0,84 0,85 0,77 0,51 0,56 0,57 1,08 1,65 1,65
Revenue *
 174 189 189 195 196 201 214 201 254 318 318
Net income *
 33 38 35 36 32 22 24 24 46 71 71
Operating profit *
 49 57 52 56 54 44 45 37 60 94 94
Total liabilities *
 19 22 16 17 85 80 76 135 158 121 121
Net debt *
 -32 -44 -43 -50 11 -2 -10 13 17 16 16
Total assets *
 161 177 177 183 252 250 251 325 405 450 450
Equity *
 143 155 161 166 166 170 175 191 248 328 328
Cash and investments *
 32 44 43 50 47 57 60 62 54 50 50

Over the past 10 years, the maximum capitalization of Meridian Bioscience, Inc. is 832, the minimum is 415.
Maximum net income 71, Minimum net income 22.
The maximum price of VIVO shares is 20.1699, the minimum price is 9.74.

.

VIVO valuation

Year
 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 TTM
P/E
 19,12 21,86 18,63 19,59 19,59 27,42 28,52 17,01 15,91 11,40 15,24
P/B
 4,47 5,36 4,02 4,20 3,79 3,49 3,88 2,17 2,97 2,48 3,32
P/S
 3,68 4,41 3,43 3,57 3,22 2,94 3,19 2,06 2,90 2,56 3,42
E/P
 5% 5% 5% 5% 5% 4% 4% 6% 6% 9% 7%
P/FCF
 16,97 20,20 20,71 18,30 19,01 16,03 22,24 12,94 16,45 16,76 22,42
.

VIVO profitability

Year
 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 TTM
ROE
 23% 25% 22% 21% 19% 13% 14% 13% 19% 22%
ROA
 26% 26% 24% 23% 20% 13% 14% 14% 22% 28%
ROIC
 34% 37% 32% 33% 23% 19% 20% 12% 17% 23%